Improved Composite Hydrogel for Bioengineered Tracheal Graft Demonstrates Effective Early Angiogenesis.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Current tracheal graft bioengineering uses high collagen hydrogels, limiting cell infiltration.
• High collagen hinders cell migration essential for graft integration and function.

Purpose of the Study:

• To develop and characterize improved collagen-agarose hydrogels with reduced collagen concentrations (<5 mg/mL).
• To assess the capacity of these novel hydrogels for fibroblast invasion and early angiogenesis.

Main Methods:

• Created four collagen-agarose hydrogel blends with varying collagen (1-2 mg/mL) and agarose (0.125-0.25%) concentrations.
• Seeded hydrogels with fibroblasts and co-cultured endothelial cells and fibroblasts.
• Assessed fibroblast migration, endothelial cell morphology, alpha-smooth muscle actin (aSMA) expression, and vascular endothelial growth factor (VEGF) gene expression at 7 days.

Main Results:

• Hydrogels with lower agarose concentrations (0.125%) facilitated superior fibroblast attachment and migration.
• Low-agarose gels promoted endothelial cell elongation, branching, and self-assembly into angiogenic structures.
• Positive aSMA immunostaining and increased VEGF gene expression were observed in low-agarose gels.

Conclusions:

• Collagen-agarose hydrogels with low agarose concentrations support early cellular infiltration and angiogenesis.
• These improved hydrogels show promise as cell substrates for bioengineered tracheal grafts.
• The hydrogel blend is designed for integration with 3D printed scaffolds and ECM for off-the-shelf implants.